Medigard Limited announced audited earnings results for the year ended on June 30, 2017. For the year, the company’s revenue was AUD 65,295 compared to AUD 44,236 a year ago. Loss before income tax expenses was AUD 122,690 compared to profit before income tax expenses of AUD 81,020 a year ago. Net loss for the year after income tax expense was AUD 122,690 as compared to net profit for the year after income tax expense of AUD 81,020 a year ago. Basic and diluted loss per share was 0.13 cents as compared to basic and diluted earnings per share of 0.09 cents a year ago. Net cash used in operating activities was AUD 188,084 as compared to AUD 206,945 a year ago.